AI in Digital Health: What Building a Pan-European Wellness Platform Actually Taught Me

There’s a peculiar thing that happens when you spend time in the digital health space. You attend conferences where speakers talk about AI transforming healthcare. They show beautiful product demos. They cite impressive engagement statistics. They tell you about the future.

Then you go back to actually running a digital health platform, and you discover that most of those speakers haven’t had to make a single decision that costs real money or affects real patients.

I recently spent over a year leading product and marketing strategy for a health and wellness insurtech platform operating across seven European markets, serving over 140,000 paid subscribers. I conducted 90+ vendor evaluations for AI-driven health technology. I built financial models, designed platform architecture, and had to explain our strategy to one of Europe’s largest insurance groups.

Here’s what I actually learned about AI in digital health — the stuff that doesn’t make it into the conference decks.

The AI Problem That Nobody Talks About

Every digital health company claims to use AI. Very few of them can explain precisely what problem it’s solving.

When I started evaluating AI vendors for a next-generation health platform, I began every conversation with the same question: “What behaviour change does your AI actually produce?” Not what data it analyses. Not what scores it generates. What does someone do differently as a result of your product being in their life?

The answers were revealing. Most vendors had sophisticated data science but couldn’t connect it to meaningful health outcomes. They could tell you a user’s “wellness score.” They couldn’t tell you whether that score correlated with fewer GP visits, reduced sick days, or better chronic disease management.

This matters enormously in healthcare, because the ultimate payer — whether that’s an insurer, an employer, or a government — only cares about outcomes. A beautiful AI-powered engagement platform that doesn’t change health behaviours is a very expensive hobby.

Most AI in digital health is solving the problem of looking innovative rather than the problem of making people healthier.

The European Complexity Nobody Accounts For

Digital health companies love to talk about “European expansion.” What they mean, usually, is that they’ve translated their app into German and French.

Real European expansion in healthcare is categorically different from any other B2C category I’ve worked in — and I’ve managed marketing across 63 markets in other sectors. Here’s why:

Regulatory frameworks don’t just vary — they contradict each other. What’s permissible health data usage in Germany is illegal in France. What constitutes a medical device in one jurisdiction is a wellness app in another. GDPR adds a baseline complexity that varies in interpretation by market. If you’re building an AI health platform and you haven’t mapped your data architecture against each country’s specific health data regulation, you will eventually hit a wall that stops your product dead.

Healthcare systems shape consumer behaviour in ways your product team won’t anticipate. In Germany, healthcare is a right and a deeply bureaucratic one. Preventive wellness products fight against a cultural belief that health management is the doctor’s job, not yours. In Italy, family networks informally manage health decisions in ways that make individual health apps a harder sell. In Poland, digital health adoption is surprisingly high, partly because the public healthcare system has significant gaps that digital products can fill.

These aren’t marketing nuances. They’re fundamental differences in the Jobs To Be Done your product needs to fulfil. You cannot AI your way around them.

Partnership complexity scales non-linearly. We managed relationships with major technology and device partners across seven countries. Each partnership had country-specific contractual terms, different integration requirements, and distinct regulatory compliance obligations. What looks like one partner relationship is actually seven different relationships with seven different legal frameworks. The AI vendor evaluations I ran had to account for which platforms could genuinely operate compliantly across all markets — not just most of them.

What 90+ Vendor Evaluations Taught Me About AI Maturity

When you evaluate 90+ AI and digital health vendors over several months, patterns emerge that you won’t find in market analyst reports.

First: the gap between demo and deployment is enormous. The AI that works beautifully in a demo environment — curated data, controlled variables, favourable use cases — frequently behaves very differently on messy real-world data from real users with real health histories and real behavioural variability. I saw this repeatedly. Products that looked transformative in evaluation were significantly less impressive when we stress-tested them against our actual user population.

Second: most AI health products are built for the US market and awkwardly retrofitted for Europe. This sounds obvious, but the implications go deeper than translation. Training data is often US-centric, which affects the AI’s recommendations for populations with different dietary patterns, healthcare behaviours, and disease prevalence. A nutrition AI trained primarily on American eating patterns will give odd recommendations to Central European users.

Third: the best vendors obsess about the “activation moment” — the specific point where AI-generated insight becomes user action. The worst vendors obsess about the sophistication of their algorithms. Both can generate impressive insight. Only one generates behaviour change.

Fourth: AI in health must be explainable to users who are, rightly, sceptical. “Our algorithm determined your wellness score is 73” creates anxiety and distrust. “Based on your activity this week, here’s one specific thing that would improve your sleep” creates engagement. The AI that wins in consumer health is the AI that users trust enough to act on — not the AI that’s technically most sophisticated.

The AI that wins in consumer health isn’t the most sophisticated. It’s the one users trust enough to actually act on.

The Business Model Problem AI Cannot Solve

Here’s the insight I wish someone had shared with me before I started: in digital health, the business model problem is usually harder than the technology problem.

Getting consumers to engage with health apps is genuinely hard. People download health apps with good intentions and abandon them within weeks. The engagement statistics that digital health companies cite are usually carefully chosen to highlight their best cohorts rather than represent average user behaviour.

AI can improve engagement at the margin. It can personalise content, optimise notification timing, and identify users at risk of churning. What AI cannot do is make a fundamentally broken unit economics model work.

If your customer acquisition cost is high, your premium conversion rate is low, and your average revenue per user doesn’t cover your infrastructure and content costs — no amount of AI optimisation closes that gap. You’re just building a more expensive version of something that doesn’t work.

I diagnosed exactly this situation in my platform. Beautiful product. Real engagement data. An AI roadmap that would have impressed any investor. And unit economics that simply didn’t stack up against eight years of historical data. The decision to restructure rather than continue wasn’t a failure of the AI strategy. It was a recognition that technology cannot save a broken business model.

What This Means If You’re Building in Digital Health Now

The investment into AI-driven health platforms will continue. The regulatory environment is maturing. The technology is genuinely improving. There are real opportunities.

But if you’re building in this space — whether as a founder, a product leader, or a marketing executive — here’s what I’d tell you:

Start with the outcome, not the technology. What does health success look like for your specific user population? How will you measure it? What’s the mechanism by which your AI actually produces that outcome? If you can’t answer these questions precisely, you’re building technology theatre, not health infrastructure.

Design for the regulatory environment from day one, not as an afterthought. European health data regulations are only getting stricter. Building compliance in retrospectively is enormously expensive. The companies that will win are the ones that treat regulatory compliance as a product feature, not a legal obstacle.

Respect the complexity of European markets. The EU is not a single market in health. It’s 27 different markets with different healthcare systems, different cultural relationships with health, and different regulatory frameworks. Your AI product needs to work in all of them, not just the easy ones.

Be honest about your unit economics before you optimise. The question isn’t whether AI can improve your conversion rate by 15%. The question is whether you have a business model that works at scale. If not, fix that first.

Digital health is a hard category. The opportunity is real. But the graveyard of well-funded, beautifully designed, AI-powered health platforms that couldn’t figure out the business model is growing.

The AI problem in digital health is almost never the AI.